Timothy K. Lu is CEO at Senti Biosciences, Inc. (SNTI). They have made 1 open-market trade across 1 company since 2025, most recently 2026-03-09.
CIK 0001852301
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SNTI | 639,583 | $138K |
Shares reported on the most recent Form 4, priced at the 2026-03-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNTI | SELL | 2025-02-04 | 2025-02-06 | $4.11 | $18K | -8.6% | -21.7% | -25.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.